Decreased risk of cancer of the UADT associated with the use of non-COX-2 inhibitors, NSAIDs and long-term aspirin therapy, »
04/02/14

Osthole decreased proliferation and cell viability of cancer cells in a dose-dependent manner. »
11/05/14

ABCC4 knockdown in 5-fluorouracil (5-FU)-resistant cancer cells restored 5-FU sensitivity. »
09/01/14

Rilotumumab had an exposure-dependent treatment effect in patients with MET-positive gastric cancer. »
09/04/14

The amino acid substitution suggests a profound effect of the substrate binding capability. »
01/16/14

Gut microbiota as an important effector in the relationship between diet and cancer. »
10/06/14

Dosing BEV at half the standard dose for progressive/recurrent GBM was at least equivalent to or, maybe better than standard dosing. »
09/03/14

QOL assessment revealed no changes over time. »
10/02/14

lipo-Nter of a bacterial-derived recombinant lipoprotein appears to be novel adjuvant. »
11/26/13

Transfection with miR‑146b‑5p decreased the mRNA and protein expression levels of C‑X‑C chemokine receptor type 4. »
02/15/14